Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-28

FDA Approved: PIRFENIDONE — Original Application (Sandoz Inc)

View source ↗

Summary

The FDA approved Sandoz Inc's original application for a generic pirfenidone product for treatment of idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

ORIG AP for PIRFENIDONE (PIRFENIDONE)